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Lactococcus lactis possesses an ATP-dependent drug
extrusion system which shares functional properties
with the mammalian multidrug resistance (MDR)
transporter P-glycoprotein. One of the intriguing
aspects of both transporters is their ability to interact
with a broad range of structurally unrelated amphi-
philic compounds. It has been suggested that P-glyco-
protein removes drugs directly from the membrane.
Evidence is presented that this model is correct for the
lactococcal multidrug transporter through studies of
the extrusion mechanism of BCECF-AM and cationic
diphenylhexatriene (DPH) derivatives from the mem-
brane. The non-fluorescent probe BCECF-AM can be
converted intracellularly into its fluorescent derivative,
BCECF, by non-specific esterase activities. The
development of fluorescence was decreased upon
energization of the cells. These and kinetic studies
showed that BCECF-AM is actively extruded from the
membrane before it can be hydrolysed intracellularly.
The increase in fluorescence intensity due to the
distribution ofTMA-DPH into the phospholipid bilayer
is a biphasic process. This behaviour reflects the fast
entry of TMA-DPH into the outer leaflet followed by
a slower transbilayer movement to the inner leaflet of
the membrane. The initial rate ofTMA-DPH extrusion
correlates with the amount ofprobe associated with the
inner leaflet. Taken together, these results demonstrate
that the lactococcal MDR transporter functions as a
'hydrophobic vacuum cleaner', expelling drugs from
the inner leaflet of the lipid bilayer. Thus, the ability
of amphiphilic substrates to partition in the inner
leaflet ofthe membrane is a prerequisite for recognition
by multidrug transporters.
Keywords: BCECF-AM/Lactococcus/multidrug
resistance/P-glycoprotein/TMA-DPH
Introduction
The development ofmultidrug resistance (MDR) in human
tumour cells is due to the overexpression ofthe membrane-
associated P-glycoprotein (P-gp), encoded by the MDR1
gene (Gottesman and Pastan, 1993). P-gp mediates the
active extrusion ofa number ofunrelated toxic compounds
resulting in a decrease in intracellular drug concentration,
and hence an increase in drug resistance (Horio et al.,
1988). Currently, multidrug transporters have been charac-
terized from mammalian cells, lower eukaryotes (Foote
et al., 1989), bacteria (Nikaido, 1994) and archaea
(Miyauchi et al., 1992). Most of the eukaryotic multidrug
transporters belong to the ATP-binding cassette (ABC)
family of transport proteins (Higgins, 1992), while the
prokaryotic systems are mainly secondary transporters.
Recently, we identified the first structural and functional
prokaryotic homologue of P-gp, designated LmrA, in
Lactococcus lactis strain MG1363 (H.W.van Veen et al.,
manuscript submitted). Functional evidence for the exist-
ence of this system was obtained previously from the
analysis ofMDR mutants ofL.lactis (Bolhuis etal., 1994),
some ofwhich also express the secondary MDR transporter
LmrP (Bolhuis et al., 1995). The substrate 'specificity' of
the lactococcal MDR transporters is very similar to that
of P-gp. It is most intriguing how these transporters
recognize, bind and transport such a broad range of
structurally and functionally unrelated compounds. Insight
into this phenomenon is of major importance for the
rational design of alternative drugs which could block or
circumvent drug pumping by multidrug transporters. Many
MDR substrates are cationic, lipophilic and planar mole-
cules. On theoretical grounds it can be predicted that
hydrophobic ions or hydrophobic compounds with polariz-
able groups will be stabilized and concentrated at the
membrane-water interface (Lauger and Neumcke, 1973;
Andersen, 1978). This is due to opposing hydrophobic
and hydrophilic interactions which pull the ion into both
phases. Forexample, anthracyclines interact with phospho-
lipid bilayers in such a way that these amphipathic
compounds have their hydrophobic parts buried between
the hydrocarbon chains, and the positively charged amino-
sugar group in the polar headgroup region of the lipids
(De Wolf et al., 1991). Ion pairing of the positively
charged amino-sugar group of anthracyclines with acidic
phospholipids also seems to be of importance (Speelmans
et al., 1994).
Based on the above-mentioned characteristics of MDR
substrates, an alternative model for drug extrusion was
proposed which differs from thatofa 'classical' transporter
in which the substrate is recognized and bound from the
aqueous phase before it is transported across the mem-
brane. In contrast, this model suggests that the hydrophobic
compounds are removed from the membrane, thereby
functioning as a 'hydrophobic vacuum cleaner' (Raviv
et al., 1990). A mechanism via which substrates are
expelled from the membrane was proposed by the 'flip-
pase' model (Higgins and Gottesman, 1992; Higgins,
1994), in which the transporter binds substrates located
in the inner leaflet of the membrane. Subsequently, sub-
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strates are translocated (flipped) from the inner to the
outer leaflet of the lipid bilayer from where they can
diffuse into the external medium, or alternatively, are
directly expelled from the inner leaflet into the external
medium. The flippase model is supported by the ability
of the mouse P-gp homologue mdr2 to catalyse the
ATP-dependent transbilayer movement of a fluorescent
phosphatidylcholine (PC) analogue (Ruetz and Gros,
1994), and the inability of an mdr2 knock-out mouse to
secrete PC into bile (Smit et al., 1993).
However, the exact molecular mechanism by which
P-gp mediates drug efflux remains unclear. Evidence for
pumping of colchicine and vinblastine (Stein et al., 1994)
from the membrane as well as for pumping ofdaunomycin
and rhodamine 6G (Muilder et al., 1993; Altenberg et al.,
1994) from the cytoplasm has been presented. In fact,
evidence presented for both models is based on the
assumption that the initial rate of passive drug influx is
unaffected by P-gp if substrates are pumped from the
cytoplasm, while the initial influx rate will decrease when
substrates are actively extruded from the membrane.
Additional evidence for drug pumping from the membrane
was based on experiments using BCECF-AM [2',7'-bis-
(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxy-
methyl ester] and other acetoxymethyl (AM) esters of
fluorescent intracellular indicators (Homolya et al., 1993;
Hollo et al., 1994).
In order to unravel further the molecular mechanism of
substrate binding by P-gp and its homologues, the effect
ofdrug partitioning in the membrane on the drug pumping
action of the lactococcal ATP-dependent MDR transporter
was studied. Our data revealed that amphiphilic drugs are
transported from the inner leaflet of the phospholipid
bilayer.
Results
BCECF-AM extrusion is mediated by the
lactococcal ATP-dependent MDR transporter
The hydrophobic acetoxymethyl derivative (BCECF-AM)
can be used to load cells with the fluorescent pH indicator
BCECF. BCECF-AM is non-fluorescent and diffuses
across the cytoplasmic membrane. Once inside the cell,
BCECF-AM is rapidly hydrolysed by non-specific
esterases, thereby trapping the non-permeant hydrophilic
free acid BCECF within the cell. In eukaryotic cells, the
human P-gp is able to reduce the accumulation of BCECF
(Homolya et al., 1993).
Transport experiments with BCECF-AM as substrate
confirm the functional similarity between P-gp and the
ATP-dependent MDR transporter of L.Iactis. Figure 1
shows that BCECF accumulates after the addition of
BCECF-AM to pre-energized wild-type cells and cells of
a mutant which has an increased resistance to ethidium
bromide (EthR). This mutant predominantly expresses
the lactococcal P-gp homologue (Bolhuis et al., 1994).
Strikingly, intracellular trapping of the fluorescent probe
is strongly reduced in the EthR mutant as compared with
the wild-type, when the cells are energized. In contrast,
BCECF-AM hydrolysis rates were identical for both cell
types in the absence of an energy source and in cell-free
extracts of both cell types (data not shown). These data
show that the rate of BCECF-AM hydrolysis is the same
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Fig. 1. BCECF-AM extrusion from Liactis. Washed cell suspensions
(0.i mg protein/ml) of either L.lactis MG1363 (A) or the drug-
resistant mutant EthR (B), were incubated without (N.E.) or with
(E) 10 mM arginine for 5 mi in the presence of nigericin (1 )M).
Ortho-vanadate (0.5 mM; Van) or reserpine (10 stg/ml; Res) were
added before energization. After the addition of 1 hM of BCECF-AM.
the BCECF fluorescence (arbitrary units, a.u.) caused by intracellular
hydrolysis of BCECF-AM by non-specific esterases, was followed in
time. The inset depicts a detail of the initial BCECF accumulation
over the first 9 s in the EthR strain in the presence (t) and absence
()tof reserpine and in the wild-type strain (A).
in the wild-type and Ethr strain and suggest that the
observed difference in BCECF accumulation between the
EthcR mutant and wild-type cells is the result of ATP-
dependent extrusion of BCECF-AM in EthmRi. This notion
was confirmed by using reserpine, a known inhibitor of
several MDR transporters, and the ABC transporter and
P-type ATPase inhibitor ortho-vanadate to inhibit the
lactococcal MDR transporter. Both inhibitors enhanced
BCECF accumulation in the EthR strain but only slightly
affected BCECF accumulation in wild-type cells. Dissip-
ation of the proton motive force upon addition of valino-
mycinplusnigericin did not affect the BCECF fluorescence
in either strain (data not shown). The effect of the ATP-
dependent BCECF-AM extrusion on the initial rate of
BCECF accumulation is shown in the inset of Figure 1.
The initial rate of BCECF accumulation is reduced in the
EthR strain as compared with the wild-type strain, and is
enhanced upon addition ofreserpine. The decreased initial
rate of BCECF-AM uptake in the EthR strain is consistent
with substrate pumping from the membrane as was
observed for the P-gp-mediated transport of colchicine
and vinblastine (Stein et al., 1994). Although L.lactis
possesses an ATP-dependent BCECF extrusion system
(Molenaar etal., 1992), the observed BCECF fluorescence
development in the wild-type and EthR strains cannot be
explained by this system. BCECF itself is not a substrate
of the ATP-dependent drug transporter since: (i) a BCECF
extrusion mutant, with a 5-fold reduced rate of BCECF
extrusion (Molenaar et al., 1992) is not affected in drug
sensitivity or drug transport; (ii) BCECF efflux from the
wild-type strain is insensitive to reserpine; and (iii) EthR
cells catalyse BCECF efflux with characteristics compar-
able with those of the wild-type strain (data not shown).
P-gp-mediated BCECF-AM extrusion was concluded
to occur from the membrane based on the assumption that
the limiting step in BCECF accumulation is BCECF-
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AM diffusion over the membrane and not BCECF-AM
hydrolysis (Homolya et al., 1993). If this assumption is
correct, the apparent affinity constant (Kin) for BCECF-
AM hydrolysis should be higher in whole cells than in
permeabilized cells, since a diffusion-limited process leads
to a cytoplasmic BCECF-AM concentration for the
esterases that is lower than the concentration added to the
cell suspension. To test whether BCECF-AM hydrolysis
in intact cells is indeed limited by the diffusion of the
probe across the membrane, the kinetics of BCECF
fluorescence development was determined in non ener-
gized wild-type cells and cells permeabilized with nisin,
a pore-forming lantibiotic peptide which allows the free
entrance of molecules like BCECF-AM (Driessen et al.,
1995), and a sonicated cell suspension. The apparent Km
measured was a factor of 2 higher in whole cells (Km
1.43 + 0.21 jiM) than in permeabilized cells (Km 0.67 ±
0.07) or a sonicated cell suspension (Km 0.70 ± 0.10 IOM).
The Vmax values in intact and permeabilized cells were
identical. Taken together, these results show that the
hydrolysis of BCECF-AM is limited by diffusion and
suggest that BCECF-AM can be excreted by the ATP-
dependent drug transporter of L.lactis and that the trans-
porter accepts the substrate from the membrane rather
than from the cytoplasm.
Molecular mechanism of TMA-DPH partitioning
into the phospholipid bilayer
To strengthen the conclusion that drug extrusion occurs
from the membrane, an alternative assay was used which
is based on the active efflux ofcationic diphenylhexatriene
(DPH) derivatives. The amphiphilic character and the high
lipid-water partition coefficients results in partitioning of
the probe into the phospholipid bilayer, with the charged
headgroup positioned between the lipid headgroups and
the DPH moiety buried in the non-polar hydrocarbon
phase of the membrane (Prendergast et al., 1981). The
hydrophobic compounds are only fluorescent when parti-
tioned into the membrane (Prendergast et al., 1981), and
the fluorescence reflects the concentration of the probe in
the membrane (Kuhry et al., 1985). From TMA-DPH
{ 1-[4-(trimethylamino) phenyl]-6-phenylhexa-1,3,5-triene}
binding experiments under conditions of equilibrium we
could calculate a cell membrane-associated probe concen-
tration of 5 mM while the extracellular free concentration
was only 30 nM (data not shown). This yields a lipid over
medium partition coefficient of 105, which is in agreement
with the octanol/water Kp for TMA-DPH of 2X 105
(Haugland, 1992). Addition ofTMA-DPH to L.lactis cells
resulted in a biphasic increase in fluorescence due to the
association ofTMA-DPH with the cytoplasmic membrane
(Figure 2; phase A and B). A rapid (1-2 s) initial
fluorescence increase, resulting from the immediate inser-
tion of TMA-DPH into the lipid bilayer (phase A), is
followed by a slower fluorescence increase (phase B)
which reaches its maximum after several minutes. A
similarbiphasic increase in fluorescence was also observed
when TMA-DPH was added to liposomes (not shown).
Fluorescence resonance energy transfer (FRET)
measurements in liposomes were carried out to investigate
this biphasic behaviour in greater detail. Energy transfer
between two fluorescent molecules is possible if the
emission wavelength of the donor molecule and the
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Fig. 2. Kinetics of TMA-DPH association with the cytoplasmic
membrane. The time-course of fluorescence development upon
addition of 200 nM of TMA-DPH to a washed cell suspension
(0.4 mg protein/ml) of L.iactis EthR, reveals two distinct fluorescent
phases (A and B). Subsequently (Trace I). cells were energized with
25 mM of glucose (G; left vertical axis), or (Trace II) cells were
diluted 10-fold before energization (G; right vertical-axis).
excitation wavelength of the acceptor molecule overlap,
provided that the donor and acceptor molecule are in close
proximity (for a review, see Matyus, 1992). In this assay,
the donor and acceptor molecules were TMA-DPH and
the fluorescent phospholipid derivative NBD-PE [N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine], respectively. An emis-
sion spectrum of liposomes containing 0.5 mol% NBD-
PE at the excitation wavelength of TMA-DPH (350 nm)
revealed no NBD-PE fluorescence (540 nm) (data not
shown), whereas liposomes equilibrated with TMA-DPH
but lacking NBD-PEyielded atypical TMA-DPH emission
spectrum (maximum at 425 nm). However, liposomes
containing both NBD-PE and TMA-DPH gave a clear
signal at the emission maximum of NBD-PE, whereas the
fluorescence at the emission maximum of TMA-DPH was
low. These results show that efficient energy transfer
occurs from TMA-DPH to the NBD moiety of NBD-PE.
To discriminate between the fluorescence of NBD-PE
located in the outer and inner leaflet of the phospholipid
bilayer, the membrane impermeable quencher DPX
(p-xylene-bis-pyridinium bromide) was used. DPX added
to the external medium solely quenches the fluorescence
ofNBD-PE molecules located in the outer leaflet. Fluores-
cence resonance energy transfer between TMA-DPH and
NBD-PE in liposomes displayed biphasic kinetics (Figure
3). In the presence ofDPX, however, the total fluorescence
decreased to ~50%, due to a decrease in phase A but not
in phase B fluorescence. The NBD-PE fluorescence was
completely quenched when DPX was allowed to enter the
liposomes by sonication. The results show that -50% of
the TMA-DPH is present in the outer leaflet of the
liposomal membrane. These experiments suggest that the
initial TMA-DPH fluorescence is due to the fast parti-
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Fig. 3. Fluorescent behaviour of TMA-DPH in phospholipid bilayers.
Time-dependent FRET from TMA-DPH to NBD-PE. Energy transfer
was followed in time upon addition of TMA-DPH (150 nM) to an
NBD-PE containing DOPG/DOPC liposomes (3/1) suspension. The
NBD-PE fluorescence was followed in the absence (Trace I) or
presence (Trace II) of 200 mM DPX. The NBD-PE fluorescence when
DPX was present both intra- and extracellularly was measured after
sonication of the suspension (dotted line).
tioning of the probe in the outer leaflet of the phospholipid
bilayer (phase A), followed by a slower transbilayer
movement (flip-flop) of the probe from the outer to the
inner leaflet of the bilayer (phase B). The insertion of
TMA-DPH into the liposomes is similar to the biphasic
fluorescent behaviour of TMA-DPH observed in intact
cells (Figure 2B) and indicates a similar mechanism of
partitioning.
DPH derivatives are substrates of the lactococcal
ATP-dependent MDR transporter
Energy-dependent TMA-DPH extrusion from the mem-
brane of L.iactis EthR is shown in Figure 2. TMA-DPH
extrusion in the direction of the partitioning equilibrium
was assayed after a 10-fold dilution of cells preincubated
with TMA-DPH, i.e. 90% of the cells (volume) was
removed and replaced by an equal volume of buffer
(Figure 2; trace II). Dilution of cells loaded with TMA-
DPH resulted in a rapid fluorescence decrease from 809
units to 102 units, which is less than expected when all
TMA-DPH would redistribute instantaneously over the
membrane and external medium compartments. Sub-
sequently, a slow additional fluorescence decrease was
observed which reflects the actual release of TMA-DPH
from the outer leaflet of the membrane into the medium
until a new equilibrium between membrane-associated
and unbound TMA-DPH was reached. The subsequent
rapid fluorescence decrease upon energization of the cells
by the addition of glucose points to the active extrusion
of TMA-DPH from the membrane (Figure 2; trace II). A
decrease in TMA-DPH fluorescence was also observed
when cells were preincubated with TMA-DPH and glucose
was added after 5 min (Figure 2; trace I). Apparently,
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Fig. 4. TMA-DPH fluorescence in L.iactis. (A) Washed cell
suspensions (0.1 mg protein/ml) of L.iactis MG1363 (wild-type) or the
drug-resistant mutant (EthR) were incubated for 10 min with 100 nM
of TMA-DPH before energization with 25 mM glucose (G). Reserpine
was added to a final concentration of 10 ,ug/ml. (B) The effect of
ortho-vanadate on TMA-DPH extrusion was investigated in EthR cells
pre-incubated for 10 min with or without ortho-vanadate (0.5 mM).
The cells were subsequently de-energized for 30 min with 10 mM of
2-deoxyglucose, washed and resuspended in a fresh buffer. The
decrease in TMA-DPH fluorescence was followed upon energization
with arginine (10 mM), 15 min after the addition of 100 nM TMA-
DPH.
TMA-DPH can be actively extruded against the direction
of the partitioning equilibrium.
The energy-dependent fluorescence decrease of TMA-
DPH was more extensive in EthR than in wild-type cells
and could be reversed by reserpine (Figure 4A). Ortho-
vanadate inhibited the TMA-DPH fluorescence decrease
in arginine-energized cells (Figure 4B), while dissipation
of the proton motive force upon addition of valinomycin
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Fig. 5. TMA-DPH efflux from L.iactis. Cells of the wild-type L.iactis
strain MG1363 (0) and the drug-resistant strain EthR (U) were
de-energized for 30 min with 10 mM 2-deoxyglucose and
subsequently preincubated for 1 h with 1 tM TMA-DPH. After the
addition of 25 mM glucose, the concentration of cell-associated
TMA-DPH was calculated from the amount of TMA-DPH in the
external medium.
plus nigericin did not significantly affect TMA-DPH
fluorescence (data not shown). These observations verify
the involvement of the ATP-dependent drug transporter in
TMA-DPH transport. To confirm that the decrease in
TMA-DPH fluorescence is the result of active extrusion,
the amount of free TMA-DPH in the external medium
was measured. For this purpose, the external medium was
rapidly separated from the cells by centrifugation and
the free TMA-DPH in the supernatant was measured
fluorimetrically after the addition of SDS. From these data
the amount of cell-associated TMA-DPH was calculated
(Figure 5). The excretion of TMA-DPH into the medium
as determined by this indirect assay was faster with the
EthR strain than with the wild-type strain, which is entirely
consistent with the data obtained in the direct fluorescence
assay (Figure 4A). Taken together, these results show that
TMA-DPH, a probe that is predominantly associated with
the membrane, is a substrate of the ATP-dependent drug
transporter of L.lactis.
Like TMA-DPH, the cationic DPH derivative TMAP-
DPH [N-p-(6-phenyl-{ l,3,5 hexatrienyl[phenyl-(propyl)] })
trimethyl-ammonium] was transported by the lactococcal
MDR transporter (data not shown). In contrast, no extru-
sion was observed for the neutral DMA-DPH { 1-[4-
(dimethylamino)phenyl]-6-phenylhexa- 1,3,5-triene} orthe
anionic DPH-CA (1,6-diphenylhexa- 1,3,5-triene carb-
oxylic acid). Apparently, the drug extrusion system shows
a preference for positively charged DPH derivatives.
TMA-DPH is not expelled from the outer leaflet
To determine whether TMA-DPH can be extruded from
the outer leaflet ofthe cytoplasmic membrane, the depend-
ency of the TMA-DPH efflux rate on the partitioning of
TMA-DPH in the membrane was studied. As depicted in
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Fig. 6. Time-course of the rate of energy-dependent TMA-DPH
extrusion. A washed cell suspension of L.1actis EthR was incubated
with 100 nM TMA-DPH. Subsequently, cells were energized with
25 mM grlucose, at 5 (A), 15 (B) and 40 min (C) after the addition of
TMA-DPH.
Figure 6, the initial rate of active TMA-DPH extrusion
increased in time, i.e. in the course of flipping of TMA-
DPH from the outer to the inner leaflet. The steady-state
levels obtained were identical to that observed for pre-
energized cells (data not shown). These data show that
the rate ofTMA-DPH extrusion increases with the concen-
tration ofTMA-DPH in the inner leaflet ofthe cytoplasmic
membrane.
Discussion
The mechanism of extrusion of hydrophobic compounds
by the lactococcal ATP-dependent drug extrusion system
was studied. The evidence presented is consistent with a
model for drug pumping, in which drugs are recognized
as substrates after partitioning into the inner leaflet of the
membrane. We have shown that BCECF-AM is excreted
by the ATP-dependent drug efflux system of L.lactis,
before hydrolysis by intracellular esterases. Moreover,
cationic DPH derivatives such as TMA-DPH, but not the
anionic or neutral derivatives, are actively extruded by
EthR cells. Direct fluorescence measurements revealed the
involvement of the ATP-dependent MDR transporter in
TMA-DPH extrusion (Figure 4), while the indirect assay
confirmed that TMA-DPH indeed appears in the external
medium (Figure 5). Furthermore, it was shown that the
initial rate of TMA-DPH extrusion increased when more
of the probe had accumulated in the inner leaflet of the
membrane (Figure 6).
The rate-determining steps in the extrusion of amphi-
philic, cationic drugs which readily partition into the
membrane, are the transbilayer movement (from the inner
to the outer leaflet) and the diffusion from the outer leaflet
to the extracellular water phase. This was confirmed by
the observation that the rate of passive release of TMA-
DPH from the membrane after dilution is slow compared
with the rate of active extrusion (Figure 2). This is in
accordance with observations made by Kuhry etal. (1985),
who found a similar slow redistribution after diluting
TMA-DPH-loaded mouse fibroblasts. In fact, these
researchers did not observe intracellular appearance of
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TMA-DPH within 30 min after addition of the probe. In
liposomes, TMA-DPH was found to remain membrane
associated for at least 3 h, before any internal appearance
could be measured (Cranney et al., 1983).
The partitioning of TMA-DPH into the outer leaflet of
the lipid bilayer is a fast process which is followed by a
slower translocation to the inner leaflet. This was shown
by studies in liposomes using FRET between TMA-DPH
and NBD-PE in the presence and absence ofthe membrane
impermeable quencher DPX (Figure 3). In the absence
of DPX, the fluorescence development resulting from
molecules partitioning in the inner leaflet is less apparent
than when DPX is present (compare slow phases in Figure
3; traces I and II). The reason is that molecules that flip
from the outer to the inner leaflet only contribute to the
total fluorescence intensity when the outer leaflet is
immediately refilled from the extemal free pool. Therefore,
at limiting external TMA-DPH concentrations, most of
the TMA-DPH is present in the membrane and the
fluorescence development in the second phase of the
experiment shown in Figure 3 is partially masked. Biphasic
kinetics were also observed for the partitioning of TMA-
DPH in the cytoplasmic membrane ofL.lactis cells (Figure
2), and in the lipid bilayer of blood platelets (Kitagawa
et al., 1991). Assuming normal Michaelis-Menten-like
transport kinetics, the initial efflux rates are determined
by the local substrate concentrations. Since the occupation
of the outer leaflet with TMA-DPH is fast and completed
within seconds after addition of the probe, the observed
time and hence concentration dependency of TMA-DPH
efflux rules out the outer leaflet as the possible site of
substrate binding and extrusion (Figure 6).
The lactococcal MDR transporter is able to actively
extrude BCECF-AM from cells of L.lactis. Active extru-
sion of BCECF-AM was also observed for P-gp and this
was used as an argument for substrate pumping from the
membrane rather than from the cytoplasm under the
assumption that the esterase activity is not limiting
(Homolya et al., 1993; Hollo et al., 1994). Since the
observed BCECF-AM extrusion might also be explained
by competition between the transporter and the esterases
for the cytoplasmic pool of BCECF-AM, it is essential to
show that diffusion of BCECF-AM and not hydrolysis
is the limiting step. Evidence that indeed BCECF-AM
diffusion, rather than esterase activity, is limiting the
BCECF accumulation has been presented in this study.
Since activation of the ATP-dependent drug extrusion
system of L.lactis lowers the intracellular BCECF concen-
tration, the results are most consistent with an extrusion
of BCECF-AM from the membrane.
Taken together, the observed characteristics of TMA-
DPH and BCECF-AM transport by the ATP-dependent
drug transporter of L.lactis are most consistent with a
mechanism where drugs are bound and expelled from the
membrane rather than from the cytoplasm. Furthermore,
the TMA-DPH transport studies suggest that the inner
leaflet of the lipid bilayer is the site from which the
transporter gains access to its substrates. These results are
in agreement with results reported for the human multidrug
transporter P-glycoprotein (Stein et al., 1994; Shapiro and
Ling, 1995) and forthe MDR-related protein MRP (Mulder
et al., 1993). Therefore, MDR transporters may function
as 'hydrophobic vacuum cleaners' which remove toxic
compounds from the inner leaflet of the lipid bilayer in
order to preserve the membrane integrity and functioning.
Materials and methods
Growth and preparation of organisms
L.lactis MG 1363 and the multidrug resistant mutant, EthR (Bolhuis et al.,
1994) were grown at 300C on M17 medium (Difco), supplemented with
25 mM glucose or with 25 mM galactose plus 10 mM arginine.
BCECF-AM transport
Transport and intracellular trapping of the non-fluorescent probe BCECF-
AM was determined by continuous recording of the BCECF fluorescence
development. Exponentially growing cells were harvested and washed
three times in 50 mM potassium-HEPES, pH 7.0, containing 25 mM
K,SO4 plus 5 mM MgSO4. Subsequently, the cells were resuspended in
buffer to a final concentration of 0.1 mg protein/ml. BCECF-AM (1 mM
stock solution in dimethylsulfoxide) was added to the cell suspension to
a final concentration of 0.5 MtM. BCECF fluorescence (arbitrary units)
was measured at excitation and emission wavelengths of 502 and 525 nm,
using slit widths of 5 and 10 nm, respectively. Fluorescence experiments
were performed with a Perkin-Elmer LS 50B fluorometer, equipped with
a thermostatically controlled, magnetically stirred cuvette holder.
Esterase activity measurements
The esterase activity in intact cells, cells permeabilized with nisin
(5 tg/ml), and sonicated cell suspensions, was measured at various
concentrations of BCECF-AM by following the BCECF fluorescence
development in time. The initial BCECF-AM conversion rates (in
arbitrary units/s) were determined by linear regression of the fluorescence
data over the first 5 s after addition of the probe.
TMA-DPH efflux measurements in whole cells
TMA-DPH from cells was measured via two methods: (i) direct
measurement of the amount of membrane-associated TMA-DPH;
(ii) indirect measurement of TMA-DPH in a cell-free supernatant. In
the direct efflux method, the fluorescence development upon addition of
TMA-DPH (100 nM final concentration) to a washed cell suspension
(0.1 mg protein/ml) was followed in time. The fluorescence intensity
was recorded using excitation and emission wavelengths of 350 and
425 nm, and slit widths of 5 and 10 nm, respectively. The indirect TMA-
DPH efflux experiment is based on the rapid separation of the cells from
the supernatant. A cell suspension (0.2 mg protein/ml) in 50 mM Tris-
HCI, pH 6.5, containing 20 mM KCI plus 5 mM MgSO4 was incubated
for 1 h with I tM TMA-DPH at room temperature. Samples (750 ul)
were taken from the suspension at times indicated, and cells removed
by centrifugation. From the cleared supernatant, 450 gI was carefully
pipetted and mixed with 50 pl of a 10% SDS solution. The TMA-DPH
fluorescence in this solution is linear with the probe concentration within
the range of 0 to 2 jM TMA-DPH (data not shown). The TMA-DPH
concentration was estimated from a linear calibration curve. The cell-
associated amount of TMA-DPH concentration was calculated from the
difference between the total amount of TMA-DPH added, and the actual
external TMA-DPH concentration, assuming a specific internal volume
of 3.6 gl/mg of cell protein (Poolman et al., 1987). For the calculation
of probe partitioning in the membrane, a 5 nm thickness of the
cytoplasmic membrane and a 50% occupation with proteins was assumed.
Fluorescence energy transfer experiments in liposomes
The fluorescence properties of TMA-DPH were studied in liposomes.
To identify the location of TMA-DPH during the partitioning into the
phospholipid bilayer, a model system was used consisting of DOPG/
DOPC liposomes (3/1) containing 0.5 mol% of the fluorescent phospho-
lipid NBD-PE. The fluorescence resonance energy transfer between
TMA-DPH and NBD-PE was measured using excitation and emission
wavelengths of 350 nm and 540 nm, respectively.
Materials
BCECF-AM, TMA-DPH, TMAP-DPH, DMA-DPH, DPH-CA and DPX
were obtained from Molecular Probes Inc., Eugene, OR, USA. Stock
solutions ofthe fluorescence probes were prepared in dimethyl formamide
or in dimethylsulfoxide. NBD-PE was obtained from Avanti Polar Lipids,
Inc., Birmingham, AL, USA.
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